Intravitreal ranibizumab (Sultan Qaboos University)

N/A

Report date: 2024/08/29 20:00:20

Base Information

Drug NameIntravitreal ranibizumab (Sultan Qaboos University)
Drug Alias NameN/A
ClassificationBiologics > Biosimilar
Mechanisms of ActionVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsRetinal Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSultan Qaboos University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSultan Qaboos University
Active IndicationsN/A
Inactive IndicationsRetinal Dystrophies

Other Information

ATC CodeS01LA04
Related LinksN/A